⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30813458 | 1.00 | — | — | |
| SCHEMBL27217993 | 0.93 | SRC (0.31) | — | |
| SCHEMBL30813431 | 0.92 | SRC (0.36) | — | |
| SCHEMBL30813443 | 0.90 | FLT3 (0.38) | — | |
| SCHEMBL30813586 | 0.88 | RET (0.35) | — | |
| SCHEMBL27217810 | 0.88 | SRC (0.36) | — | |
| SCHEMBL27217840 | 0.86 | FLT3 (0.37) | — | |
| SCHEMBL27217839 | 0.85 | RET (0.34) | — | |
| SCHEMBL30813527 | 0.83 | KDR (0.37) | — | |
| SCHEMBL30813564 | 0.82 | SRC (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240158394-A1 | NEK7 INHIBITORS | Halia Therapeutics, Inc. | 2024-05-16 | — | — | US | disclosed |
| WO-2024059200-A1 | NEK7 INHIBITORS | Halia Therapeutics, Inc. (US) | 2024-03-21 | — | — | WO | disclosed |